BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25026005)

  • 1. [Does the hospital cost of care differ for inflammatory bowel disease patients with or without gastrointestinal infections? A case-control study].
    Schmidt C; Köhler F; Kräplin T; Hartmann M; Lerch MM; Stallmach A
    Z Gastroenterol; 2014 Jul; 52(7):643-8. PubMed ID: 25026005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.
    Ananthakrishnan AN; McGinley EL; Binion DG
    Gut; 2008 Feb; 57(2):205-10. PubMed ID: 17905821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence of and associated mortality with methicillin-resistant Staphylococcus aureus among hospitalized IBD patients.
    Nguyen GC; Patel H; Chong RY
    Am J Gastroenterol; 2010 Feb; 105(2):371-7. PubMed ID: 19809406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
    Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
    Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Economic burden of Clostridium difficile enterocolitis in German hospitals based on routine DRG data].
    Grube RF; Heinlein W; Scheffer H; Rathmayer M; Schepp W; Lohse AW; Stallmach A; Wilke MH; Lerch MM;
    Z Gastroenterol; 2015 May; 53(5):391-7. PubMed ID: 25965986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Expenditures for Academic Inpatient Care of Inflammatory Bowel Disease Patients Are Almost Double Compared with Average Academic Gastroenterology and Hepatology Cases and Not Fully Recovered by Diagnosis-Related Group (DRG) Proceeds.
    Baumgart DC; le Claire M
    PLoS One; 2016; 11(1):e0147364. PubMed ID: 26784027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Integrated management of patients with chronic inflammatory bowel disease in the Rhine-Main Region: results of the first integrated health-care project IBD in Germany].
    Blumenstein I; Tacke W; Filmann N; Zosel C; Bock H; Heuzeroth V; Zeuzem S; Schröder O
    Z Gastroenterol; 2013 Jul; 51(7):613-8. PubMed ID: 23696113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National burden of pediatric hospitalizations for inflammatory bowel disease: results from the 2006 Kids' Inpatient Database.
    Heaton PC; Tundia NL; Schmidt N; Wigle PR; Kelton CM
    J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):477-85. PubMed ID: 22027564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost evaluation of a model for integrated care of seriously mentally ill patients].
    Fischer F; Hoffmann K; Mönter N; Walle M; Beneke R; Negenborn S; Weinmann S; Willich SN; Berghöfer A
    Gesundheitswesen; 2014 Feb; 76(2):86-95. PubMed ID: 23737155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease.
    Hanada Y; Khanna S; Loftus EV; Raffals LE; Pardi DS
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):528-533. PubMed ID: 29037938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
    Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
    J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.
    Nguyen GC; Kaplan GG; Harris ML; Brant SR
    Am J Gastroenterol; 2008 Jun; 103(6):1443-50. PubMed ID: 18513271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Costs of ambulant care for patients with inflammatory bowel disease in general practice].
    Beiche A; König HH; Ebinger M; Matysiak-Klose D; Braun V; Leidl R
    Z Gastroenterol; 2003 Jun; 41(6):527-36. PubMed ID: 12806538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.
    Nguyen GC; Sam J
    Am J Gastroenterol; 2008 Sep; 103(9):2272-80. PubMed ID: 18684186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: a single metropolitan Australian center experience.
    van Langenberg DR; Simon SB; Holtmann GJ; Andrews JM
    J Crohns Colitis; 2010 Oct; 4(4):413-21. PubMed ID: 21122537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Direct medical costs of (severe) obesity: a bottom-up assessment of over- vs. normal-weight adults in the KORA-study region (Augsburg, Germany)].
    von Lengerke T; Reitmeir P; John J
    Gesundheitswesen; 2006 Feb; 68(2):110-5. PubMed ID: 16482491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
    Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What factors determine the direct medical costs of patients with systemic lupus erythematosus in Germany? Subanalysis of the LUCIE study].
    Richter JG; Häckel B; Manger K; Riechers E; Schmeding A; Thies W; Schneider M
    Gesundheitswesen; 2014 Jan; 76(1):41-3. PubMed ID: 23512471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
    Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
    Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.